Published in J Clin Invest on January 01, 1938
THE RENAL CLEARANCE OF ENDOGENOUS "CREATININE" IN MAN. J Clin Invest (1948) 7.93
THE DETERMINATION OF THE GLOMERULAR FILTRATION BY THE ENDOGENOUS CREATININE CLEARANCE. J Clin Invest (1940) 5.04
RENAL EXCRETION AT LOW URINE VOLUMES AND THE MECHANISM OF OLIGURIA. J Clin Invest (1938) 3.92
THE RENAL EXCRETION OF INULIN AT LOW PLASMA CONCENTRATIONS OF THIS COMPOUND, AND ITS RELATIONSHIP TO THE GLOMERULAR FILTRATION RATE IN NORMAL, NEPHRITIC AND HYPERTENSIVE INDIVIDUALS. J Clin Invest (1940) 3.23
Creatinine clearance in renal disease. A reappraisal. Br Med J (1969) 3.13
Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int (2009) 2.46
THE MODE OF EXCRETION OF CREATINE AND CREATINE METABOLISM IN THYROID DISEASE. J Clin Invest (1943) 2.36
Validity of the endogenous creatinine clearance as a measure of glomerular filtration rate in the diseased human kidney. J Clin Invest (1952) 2.27
ON THE RENAL TUBULAR EXCRETION OF CREATININE IN NORMAL MAN. J Clin Invest (1941) 2.19
Endogenous creatinine clearance and serum creatinine in the clinical assessment of kidney function. Can Med Assoc J (1968) 1.62
PROTEINURIA FOLLOWING MOMENTARY VASCULAR CONSTRICTION. J Clin Invest (1939) 1.37
Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline. J Clin Invest (1959) 1.37
Measurement of glomerular filtration rate in children with kidney disease. J Clin Invest (1952) 1.14
The applicability of eGFR equations to different populations. Nat Rev Nephrol (2013) 1.10
THE RELATION OF HIGH AND LOW UREA CLEARANCES TO THE INULIN AND CREATININE CLEARANCES IN CHILDREN WITH THE NEPHROTIC SYNDROME. J Clin Invest (1941) 1.07
The effect of corticotropin (ACTH) on glomerular permeability to albumin in children with the nephrotic syndrome. J Clin Invest (1954) 1.05
Aldosterone excretion in virilizing adrenal hyperplasia. J Clin Invest (1959) 1.03
Comparison of inulin and endogenous creatinine clearance in young children. J Physiol (1952) 0.78
THE VARIABILITY OF PROTEINURIA IN THE HYPERTENSIVE COMPLICATIONS OF PREGNANCY. J Clin Invest (1939) 0.75
THE EXCRETION OF INULIN, XYLOSE AND UREA BY NORMAL AND PHLORIZINIZED MAN. J Clin Invest (1935) 45.65
Studies on Kidney Function: The Rate of Filtration and Reabsorption in the Human Kidney. Biochem J (1926) 39.02
THE RENAL EXCRETION OF CREATININE IN MAN. J Clin Invest (1935) 16.75
THE MEASUREMENT OF GLOMERULAR FILTRATION. CREATININE, SUCROSE AND UREA CLEARANCES IN SUBJECTS WITHOUT RENAL DISEASE. J Clin Invest (1937) 15.28
THE FERROCYANIDE CLEARANCE IN MAN. J Clin Invest (1936) 4.01
ANTIBODY RESPONSE TO INFECTIONS WITH TYPE III AND THE RELATED TYPE VIII PNEUMOCOCCUS. J Clin Invest (1934) 20.78
TRANSFERS OF INTRACELLULAR POTASSIUM IN EXPERIMENTAL DEHYDRATION. J Clin Invest (1944) 8.74
ANTIBODY RESPONSE TO INFECTIONS WITH TYPE II AND THE RELATED TYPE V PNEUMOCOCCUS. J Clin Invest (1934) 8.57
SIMULTANEOUS MEASUREMENTS OF THE BLOOD VOLUME IN MAN AND DOG BY MEANS OF EVANS BLUE DYE, T1824, AND BY MEANS OF CARBON MONOXIDE. I. NORMAL SUBJECTS. J Clin Invest (1944) 6.93
SIMULTANEOUS MEASUREMENTS OF THE BLOOD VOLUME IN MAN AND DOG BY MEANS OF EVANS BLUE DYE, T1824, AND BY MEANS OF CARBON MONOXIDE. II. UNDER ABNORMAL CONDITIONS, INCLUDING SECONDARY SHOCK. J Clin Invest (1944) 5.60
SERUM IODINE OF EUTHYROID SUBJECTS TREATED WITH DESICCATED THYROID. J Clin Invest (1945) 5.55
THE INTRAVENOUS GLUCOSE TOLERANCE TEST. J Clin Invest (1941) 4.56
THE FERROCYANIDE CLEARANCE IN MAN. J Clin Invest (1936) 4.01
THE CAUSE OF DEATH IN EXPERIMENTAL ANURIA. J Clin Invest (1941) 3.74
HEMODYNAMIC CHANGES IN SALT DEPLETION AND IN DEHYDRATION. J Clin Invest (1946) 3.62
PLASMA VOLUME OF DOGS IN DEHYDRATION, WITH AND WITHOUT SALT LOSS. J Clin Invest (1944) 3.59
TRANSFERS OF CELL SODIUM AND POTASSIUM IN EXPERIMENTAL AND CLINICAL CONDITIONS. J Clin Invest (1948) 3.30
THE DELETERIOUS EFFECT IN DOGS OF A DRY PROTEIN RATION. J Clin Invest (1944) 3.07
EXCHANGES OF SODIUM AND POTASSIUM IN FAMILIAL PERIODIC PARALYSIS. J Clin Invest (1948) 3.05
URINARY EXCRETION AND SERUM CONCENTRATION OF INORGANIC PHOSPHATE IN MAN. J Clin Invest (1943) 2.41
BLOOD KETONES AND SERUM LIPIDS IN STARVATION AND WATER DEPRIVATION. J Clin Invest (1944) 2.32
THE TREATMENT OF SHOCK DUE TO SALT DEPLETION; COMPARISON OF THE HEMODYNAMIC EFFECTS OF ISOTONIC SALINE, OF HYPERTONIC SALINE, AND OF ISOTONIC GLUCOSE SOLUTIONS. J Clin Invest (1946) 2.04
THE IMPORTANCE OF VOLUME AND OF TONICITY OF THE BODY FLUIDS IN SALT DEPLETION SHOCK. J Clin Invest (1947) 1.69
ADDITIVE EFFECTS OF IODINE AND THIOUREA IN THE TREATMENT OF HYPERTHYROIDISM. J Clin Invest (1946) 1.53
BIOCHEMICAL AND HEMODYNAMIC CHANGES FOLLOWING THE SUBCUTANEOUS INJECTION OF GLUCOSE SOLUTION. J Clin Invest (1947) 1.28
TUBULAR REABSORPTION OF PHOSPHATE IN THE DOG. J Clin Invest (1943) 1.22
Cardiovascular Effects of Potassium, Calcium, Magnesium, and Barium: An Experimental Study of Toxicity and Rationale of Use in Therapeutics. Yale J Biol Med (1940) 0.78
Inactive Cell Base and the Measurement of Changes in Cell Water. Yale J Biol Med (1944) 0.78
Diabetes Mellitus and Pregnancy. Yale J Biol Med (1943) 0.77